Tachycardia-induced cardiomyopathy is caused by persistent tarchyarrhythmias and is characterized by ventricular systolic dysfunction and congestive heart failure. Tachycardia-induced cardiomyopathy is usually reversible via treatment. The cornerstone in the management of disease in these patients is to achieve a normal heart rate. We report a torsades de pointes during treatment of tachycardia-induced cardiomyopathy. Intravenous magnesium sulfate and potassium were administrated, but torsades de pointes was repeated. After overdrive right ventricular pacing, torsades de pointes was terminated. Careful monitoring of the QT interval and serum electrolyte and drug levels in such patients is warranted during treatment of tachycardia-induced cardiomyopathy.
Tachycardia-induced cardiomyopathy (TC) is caused by sustained arrhythmia and typically characterized by left ventricular systolic dysfunction and congestive heart failure. Early treatment for TC includes the use of various drugs, including diuretics, anticoagulant, β-blocker, in combination with antiarrhythmic drugs. However, the combination medical therapy is known to increase the risk of prolonged QT interval, electrolyte imbalance and heart failure, which lead to serious arrhythmia such as torsades de pointes (TdP) unless they are treated properly. We present a case of TdP occurred in a patient being treated for TC and review other cases from the literature.
CASE REPORT
A 45-year-old woman presented with palpitations occurring three to four times per month over a period of one year and difficulty in breathing that lasted for one month. The patient did not undergo a cardiac evaluation before but had a history of hysterectomy due to uterine myoma. On admission, the patient had a blood pressure of 119/104 mmHg, pulse rate of 169 beat per minute (bpm), respiration rate of 22 per minute and temperature of 37℃. Complete blood cell count revealed leukocyte of 11,300/mm 3 (neutrophils 8,630/mm 3 ) and hemoglobin of 14.9 g/dl. Serum sodium and potassium were 142 mmol/L, and 4.2 mmol/L, respectively. And brain natriuretic peptide was elevated to 1120 pg/ml (normal range: 164 pg/ml or lower). Thyroid function test were normal showing T3 54 ng/ml, free T4 1.33 ng/ml and TSH 0.92 μIU/ml. However, chest radiography showed cardiomegaly and bilateral pulmonary edema (Fig. 1a) . Also, electrocardiography showed atrial fibrillation with a heart rate of 172 beats/min, and the adjusted QT interval was 450 msec (Fig. 2a) .
Echocardiogram detected severe left ventricular (LV) systolic dysfunction with LV ejection fraction of 15% and mild left ventricular dilation indicated by LV end-diastolic dimension of 59 mm (Fig. 3a) . The patient was diagnosed with tachycardia-induced cardiomyopathy and given digoxin, furosemide, spironolactone, angiotensin converting enzyme inhibitor in combination with warfarin and heparin after being admitted to an ICU.
On the first day after admission, her digoxin level was 0.51 ng/ml (normal range 0.8-2.4 ng/ml). As atrial fibrillation was still present on the second day after admission, a transesophageal echocardiography was performed. After we checked no thrombus in left atrium and left atrial appendage, amiodarone (60 mg/hr) was infused intravenously to restore sinus rhythm. To achieve car- Fig. 1 . Chest radiography showed (A) cardiomegaly with bilateral pulmonary edema at 1st day of admission and (B) decreased heart size as compared to that of 1 day of admission and disappearance of pulmonary edema at 15th day of admission. 
